438 related articles for article (PubMed ID: 10432118)
21. A novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice.
Li Q; Cheon YP; Kannan A; Shanker S; Bagchi IC; Bagchi MK
J Biol Chem; 2004 Mar; 279(12):11570-81. PubMed ID: 14688261
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
Bonfield TL; Farver CF; Barna BP; Malur A; Abraham S; Raychaudhuri B; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):677-82. PubMed ID: 12805087
[TBL] [Abstract][Full Text] [Related]
23. [Anti-atherosclerotic effects of PPAR gamma ligands].
Wakino S
Nihon Rinsho; 2004 Jan; 62(1):180-6. PubMed ID: 14737851
[TBL] [Abstract][Full Text] [Related]
24. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.
Ricote M; Li AC; Willson TM; Kelly CJ; Glass CK
Nature; 1998 Jan; 391(6662):79-82. PubMed ID: 9422508
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel markers of alternative activation and potential endogenous PPARγ ligand production mechanisms in human IL-4 stimulated differentiating macrophages.
Czimmerer Z; Varga T; Poliska S; Nemet I; Szanto A; Nagy L
Immunobiology; 2012 Dec; 217(12):1301-14. PubMed ID: 22954708
[TBL] [Abstract][Full Text] [Related]
26. [Is PPAR-gamma (peroxisome proliferator-activated receptor-gamma) implicated in the negative regulation of monocyte-macrophage activity?].
Reimund JM
Gastroenterol Clin Biol; 1999 Apr; 23(4):544-6. PubMed ID: 10416125
[No Abstract] [Full Text] [Related]
27. Differential recruitment of the coactivator proteins CREB-binding protein and steroid receptor coactivator-1 to peroxisome proliferator-activated receptor gamma/9-cis-retinoic acid receptor heterodimers by ligands present in oxidized low-density lipoprotein.
Wigren J; Surapureddi S; Olsson AG; Glass CK; Hammarström S; Söderström M
J Endocrinol; 2003 May; 177(2):207-14. PubMed ID: 12740008
[TBL] [Abstract][Full Text] [Related]
28. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
Berry A; Balard P; Coste A; Olagnier D; Lagane C; Authier H; Benoit-Vical F; Lepert JC; Séguéla JP; Magnaval JF; Chambon P; Metzger D; Desvergne B; Wahli W; Auwerx J; Pipy B
Eur J Immunol; 2007 Jun; 37(6):1642-52. PubMed ID: 17458857
[TBL] [Abstract][Full Text] [Related]
29. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
Schoonjans K; Martin G; Staels B; Auwerx J
Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
[TBL] [Abstract][Full Text] [Related]
31. Link between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal mice.
Elia EM; Pustovrh C; Amalfi S; Devoto L; Motta AB
Fertil Steril; 2011 Jun; 95(8):2534-7.e1. PubMed ID: 21382619
[TBL] [Abstract][Full Text] [Related]
32. The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids.
Schild RL; Schaiff WT; Carlson MG; Cronbach EJ; Nelson DM; Sadovsky Y
J Clin Endocrinol Metab; 2002 Mar; 87(3):1105-10. PubMed ID: 11889173
[TBL] [Abstract][Full Text] [Related]
33. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands.
Reddy RC; Keshamouni VG; Jaigirdar SH; Zeng X; Leff T; Thannickal VJ; Standiford TJ
Am J Physiol Lung Cell Mol Physiol; 2004 Mar; 286(3):L613-9. PubMed ID: 14617516
[TBL] [Abstract][Full Text] [Related]
34. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.
Zuo X; Wu Y; Morris JS; Stimmel JB; Leesnitzer LM; Fischer SM; Lippman SM; Shureiqi I
Oncogene; 2006 Feb; 25(8):1225-41. PubMed ID: 16288226
[TBL] [Abstract][Full Text] [Related]
35. Human 15-lipoxygenase: induction by interleukin-4 and insights into positional specificity.
Sigal E; Sloane DL; Conrad DJ
J Lipid Mediat; 1993; 6(1-3):75-88. PubMed ID: 8358018
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.
Thuillier P; Brash AR; Kehrer JP; Stimmel JB; Leesnitzer LM; Yang P; Newman RA; Fischer SM
Biochem J; 2002 Sep; 366(Pt 3):901-10. PubMed ID: 12069687
[TBL] [Abstract][Full Text] [Related]
37. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.
Subbarayan V; Xu XC; Kim J; Yang P; Hoque A; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
Neoplasia; 2005 Mar; 7(3):280-93. PubMed ID: 15799828
[TBL] [Abstract][Full Text] [Related]
38. Progress in cardiovascular biology: PPAR for the course.
Lazar MA
Nat Med; 2001 Jan; 7(1):23-4. PubMed ID: 11135607
[TBL] [Abstract][Full Text] [Related]
39. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG
Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757
[TBL] [Abstract][Full Text] [Related]
40. Ligand-dependent and -independent regulation of PPAR gamma and orphan nuclear receptors.
Xu HE; Li Y
Sci Signal; 2008 Dec; 1(48):pe52. PubMed ID: 19050303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
